Institutional investors hold a majority ownership of INCY through the 94.75% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2018, these large investors purchased a net $771.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SANDS CAPITAL MANAGEMENT LLC Bought 1.6 Million shares of Incyte Corp
MATRIX CAPITAL MANAGEMENT CO. LP Bought 1.2 Million shares of Incyte Corp
RBC GLOBAL ASSET MANAGEMENT (UK)... Bought 785.0 Thousand shares of Incyte Corp